COVID-19 Vaccine Could Turn Emotions All Of A Sudden
Satendra Singh | Nov 16, 2020 03:34AM ET
Since the U-turn seen by Pfizer’s vaccine for COVIE-19, while the fantasy of a COVID-free world propelled positive hopes for rapid economic recover; proved only a foul play with inflow of news that Pfizer (NYSE:PFE) CEO made $5.6 million stock sale on same day as COVID-19 vaccine update.
Once again, Pfizer going to announce crucial COVID-19 vaccine data as early as this week; could try to regenerate positive hopes among the investors. But, will it have the same impact over the emotions of the investors who believed Pfizer’s claim of 90% accuracy of its vaccine blindfolded? Especially, at the time while a plethora of queries on efficacy of the Pfizer’s vaccine still in the queue.
There is no doubt that more data from vaccine creator Moderna (NASDAQ:MRNA). is expected in the coming days, while AstraZeneca (NYSE:AZN) and its partner, the University of Oxford, may also have preliminary results in the next few weeks. Johnson & Johnson (NYSE:JNJ) has launched a new large-scale late-stage trial today to test a two-dose regimen of its experimental COVID-19 vaccine and evaluate potential incremental benefits for the duration of protection with a second dose.
Finally, I conclude that the Pfizer’s first move has resulted in extreme alertness among the investors to doubt every such claim in near futures; till its efficacy is not proved to eliminate COVID-19 completely for the earth. There is no doubt that the global equity markets have entered into an extremely overbought territory, even if a successful vaccine emerge; because the growing number of coronavirus infections has damaged the global economy up to a greater extent; which could rather take more time to resume normalcy.
Disclaimer
1. This content is for information and educational purposes only and should not be considered as investment advice or an investment recommendation. Past performance is not an indication of future results. All trading carries risk. Only risk capital be involved which you are prepared to lose.
2. Remember, YOU push the buy button and the sell button. Investors are always reminded that before making any investment, you should do your own proper due diligence on any name directly or indirectly mentioned in this article. Investors should also consider seeking advice from an investment and/or tax professional before making any investment decisions. Any material in this article should be considered general information, and not relied on as a formal investment recommendation.
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.